News

SWOG has had a busy couple of weeks!

myeloMATCH precision medicine trials in myeloid leukemias open to patient enrollment across U.S. and Canada

Longer-term data from SWOG S1826 trial confirm nivolumab-AVD benefit in Hodgkin lymphoma

Front Lines on important SWOG results make up some of my most popular posts

Custom facility consolidates five locations into one

In surgery for localized muscle-invasive bladder cancer, extended lymph node removal offers no survival benefit but does increase morbidity

The NCTN group chairs propose improvements in how we do correlative science

A new validated risk model identifies advanced cancer trial patients at highest risk for acute care use